Prednisolone AcetateThird Party Manufacturing in India

Prednisolone Acetate is a synthetic corticosteroid that works by suppressing the inflammatory response at the cellular level in the eye.

When applied topically to the ocular surface, prednisolone acetate diffuses across the corneal epithelium and binds to glucocorticoid receptors within target cells. This activated receptor complex translocates to the nucleus where it regulates gene transcription, leading to increased synthesis of lipocortin-1. Lipocortin-1 inhibits phospholipase A2, which in turn prevents the release of arachidonic acid from membrane phospholipids. By blocking this rate-limiting step, prednisolone acetate effectively halts the production of prostaglandins and leukotrienes — the primary mediators of inflammation.

The result is a broad suppression of edema, fibrin deposition, capillary dilation, leukocyte migration, and fibroblast proliferation. Unlike NSAID eye drops that only target the cyclooxygenase pathway, prednisolone acetate provides comprehensive anti-inflammatory coverage. It is particularly effective for managing severe ocular inflammation where rapid control is needed, making it a gold standard in post-operative and uveitic eye care.

Therapeutic Uses

Prednisolone Acetate Eye Drops are prescribed for the treatment of:

• Post-Operative Ocular Inflammation: First-line therapy to control inflammation after cataract surgery, corneal transplant, and vitreoretinal procedures
• Anterior Uveitis (Iritis/Iridocyclitis): Suppresses inflammation of the iris and ciliary body, preventing synechiae formation
• Allergic Conjunctivitis: Rapidly controls severe allergic inflammation unresponsive to antihistamines
• Corneal Inflammation (Keratitis): Used for non-infectious keratitis to reduce corneal scarring risk
• Scleritis and Episcleritis: Reduces deep ocular inflammation and pain
• Cystoid Macular Edema: Part of treatment protocols to reduce post-surgical macular swelling

Why Manufacturers Choose Prednisolone Acetate

Prednisolone Acetate is one of the most widely prescribed ophthalmic corticosteroids globally. Its acetate ester formulation provides enhanced corneal penetration compared to prednisolone phosphate, making it the preferred choice in clinical settings. Indian ophthalmic manufacturers have strong expertise in sterile corticosteroid production, with WHO-GMP certified facilities capable of producing preservative-free and multi-dose formats for both domestic and regulated export markets.

This makes Prednisolone Acetate eye drops a high-volume product for third party manufacturing in India, with consistent demand from hospital tenders, PCD franchise networks, and export distributors across Asia, Africa, and the Middle East.